Gemcitabine Compared With Gemcitabine and S-1 Combination Therapy in Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis.

Medicine (Baltimore) · 2015 · PMC4616522 · PMID 26334891

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

did not reach statistical significanceP < 0.05actually significant

Although several previous randomized clinical trials did not reach statistical significance in OS, we evaluated OS in 871 patients that showed clearly longer significantly in the GS arm ( P < 0.05).

also in 75,278 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.